Sotera Health (SHC) Cost of Revenue (2020 - 2026)

Sotera Health's Cost of Revenue history runs 7 years deep, the most recent figure standing at $133.0 million for Q1 2026.

• In Q1 2026, Cost of Revenue rose 11.66% year-over-year to $133.0 million; the TTM figure through Mar 2026 stood at $532.0 million (up 7.21% YoY), while the FY2025 annual figure was $518.1 million, up 4.0% from the prior year.
• Cost of Revenue for Q1 2026 stood at $133.0 million, down from $137.5 million in the prior quarter.
• The five-year high for Cost of Revenue was $137.5 million in Q4 2025, with the low at $107.9 million in Q1 2022.
• The 5-year median for Cost of Revenue is $121.1 million (2024), against an average of $121.6 million.
• The sharpest annual moves came in 2023 and 2024: Cost of Revenue gained 18.46% in 2023, then slipped 3.32% in 2024.
• Sotera Health's Cost of Revenue stood at $109.9 million in 2022, then climbed by 18.46% to $130.2 million in 2023, then slipped by 3.32% to $125.8 million in 2024, then advanced by 9.28% to $137.5 million in 2025, then dropped by 3.3% to $133.0 million in 2026.
• Business Quant data shows SHC's Cost of Revenue at $133.0 million in Q1 2026, $137.5 million in Q4 2025, and $133.8 million in Q3 2025.